FULC
Price
$7.06
Change
-$0.04 (-0.56%)
Updated
Jul 22, 04:59 PM (EDT)
Capitalization
383.25M
15 days until earnings call
RVXCF
Price
$0.11
Change
+$0.01 (+10.00%)
Updated
Jul 21 closing price
Capitalization
32.08M
Interact to see
Advertisement

FULC vs RVXCF

Header iconFULC vs RVXCF Comparison
Open Charts FULC vs RVXCFBanner chart's image
Fulcrum Therapeutics
Price$7.06
Change-$0.04 (-0.56%)
Volume$11.72K
Capitalization383.25M
Resverlogix
Price$0.11
Change+$0.01 (+10.00%)
Volume$41.26K
Capitalization32.08M
FULC vs RVXCF Comparison Chart in %
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVXCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. RVXCF commentary
Jul 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a StrongBuy and RVXCF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 23, 2025
Stock price -- (FULC: $7.10 vs. RVXCF: $0.11)
Brand notoriety: FULC and RVXCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 112% vs. RVXCF: 235%
Market capitalization -- FULC: $383.25M vs. RVXCF: $32.08M
FULC [@Biotechnology] is valued at $383.25M. RVXCF’s [@Biotechnology] market capitalization is $32.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileRVXCF’s FA Score has 1 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • RVXCF’s FA Score: 1 green, 4 red.
According to our system of comparison, both FULC and RVXCF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 3 TA indicator(s) are bullish while RVXCF’s TA Score has 6 bullish TA indicator(s).

  • FULC’s TA Score: 3 bullish, 5 bearish.
  • RVXCF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RVXCF is a better buy in the short-term than FULC.

Price Growth

FULC (@Biotechnology) experienced а -10.13% price change this week, while RVXCF (@Biotechnology) price change was +197.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.74%. For the same industry, the average monthly price growth was +18.90%, and the average quarterly price growth was +33.23%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($383M) has a higher market cap than RVXCF($32.1M). RVXCF YTD gains are higher at: 198.917 vs. FULC (51.064). FULC has higher annual earnings (EBITDA): -8.94M vs. RVXCF (-10.54M). FULC has more cash in the bank: 227M vs. RVXCF (153K). FULC has less debt than RVXCF: FULC (8.11M) vs RVXCF (17.6M). FULC has higher revenues than RVXCF: FULC (80M) vs RVXCF (0).
FULCRVXCFFULC / RVXCF
Capitalization383M32.1M1,193%
EBITDA-8.94M-10.54M85%
Gain YTD51.064198.91726%
P/E RatioN/AN/A-
Revenue80M0-
Total Cash227M153K148,366%
Total Debt8.11M17.6M46%
FUNDAMENTALS RATINGS
FULC vs RVXCF: Fundamental Ratings
FULC
RVXCF
OUTLOOK RATING
1..100
1129
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
89100
PRICE GROWTH RATING
1..100
9080
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (26) in the null industry is in the same range as RVXCF (28). This means that FULC’s stock grew similarly to RVXCF’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as RVXCF (100). This means that FULC’s stock grew similarly to RVXCF’s over the last 12 months.

FULC's SMR Rating (89) in the null industry is in the same range as RVXCF (100). This means that FULC’s stock grew similarly to RVXCF’s over the last 12 months.

RVXCF's Price Growth Rating (80) in the null industry is in the same range as FULC (90). This means that RVXCF’s stock grew similarly to FULC’s over the last 12 months.

RVXCF's P/E Growth Rating (94) in the null industry is in the same range as FULC (100). This means that RVXCF’s stock grew similarly to FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FULCRVXCF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 23 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVXCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAUHY13.170.09
+0.69%
Straumann Holding AG
FURCF10.85N/A
N/A
FORVIA SE
BZTAF10.46N/A
N/A
Boozt AB
NILTF0.03N/A
N/A
NICAN LTD.
KRMKF0.06N/A
N/A
KROMEK GROUP PLC

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ANNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-7.19%
ANNX - FULC
40%
Loosely correlated
+6.47%
VRDN - FULC
40%
Loosely correlated
+1.63%
RARE - FULC
39%
Loosely correlated
+0.30%
BMRN - FULC
38%
Loosely correlated
-1.27%
PTGX - FULC
37%
Loosely correlated
-0.47%
More

RVXCF and

Correlation & Price change

A.I.dvisor tells us that RVXCF and FULC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and FULC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVXCF
1D Price
Change %
RVXCF100%
+8.50%
FULC - RVXCF
25%
Poorly correlated
-7.19%
TELIF - RVXCF
23%
Poorly correlated
-5.76%
ATNM - RVXCF
22%
Poorly correlated
-1.17%
NGNE - RVXCF
21%
Poorly correlated
-3.04%
IDYA - RVXCF
20%
Poorly correlated
+1.02%
More